Wizard game teaches transplant kids about potions (meds)
NCT ID NCT07609303
First seen Jun 24, 2026 · Last updated Jul 10, 2026 · Updated 3 times
Summary
This study tests a tablet game called Mystic Wizard, designed to help children aged 7-14 who have received a solid organ transplant learn about their daily medications. In the game, players act as a young wizard who must give 'potions' to keep a magical flame (representing their transplanted organ) strong. After playing, 15 participants will share their thoughts in interviews and fill out questionnaires to see if the game is easy to use and engaging. The goal is to find out if this kind of game could be a helpful tool for transplant education.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Mystic Wizard tablet game
- What this could lead to
- If successful, this game could become a fun, engaging way to teach young transplant patients about their medications and care.
- What could go wrong
- This is a very small, early study with only 15 participants. It only measures opinions and usability, not health outcomes, so the game may not actually improve medication adherence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID ORGAN TRANSPLANT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Video game therapy gets bedridden patients back on their feet
- Could a cancer drug stop a deadly complication in transplant patients?
- Small study checks COVID-19 vaccine power in young cancer patients
- Supercharged immune cells take on post-transplant viruses
- Could a double-dose flu vaccine protect vulnerable transplant patients better?
- New hope for HIV patients with organ transplants: simpler drug combo under study